Dawe, PhD, as Scientific Advisor, Neuropharmacology & Translational Neuroscience, and Tomi K. Sawyer, PhD, as Strategic ...
Vietnam Investment Review on MSN
Kazia Therapeutics appoints Sudha Rao as chief scientific officer
SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the ...
Oppenheimer raised Marvell Technology's (MRVL) price target to $170 from $150 following a meeting with company executives, ...
Seragon Biosciences Inc. today announced the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development and Therapy, demonstrating that its ...
Brembo’s experience with motorbike brakes is a tell-tale design cue, while larger fluid volumes are good for brake ...
Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with ...
USA: Multiple doses of tonlamarsen reduced angiotensinogen levels more than a single dose, but did not lead to additional ...
Fireblocks Debuts Institutional Yield Tool For Stablecoins. Fireblocks is expanding its institutional toolbox with a new ...
A new study on HgTe nanocrystal photodiodes through CdS passivation and interface control shows new potential for infrared ...
Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high ...
In this study, the authors use microCT to image an intact hatchling octopus and segment major organ systems, including the vascular, respiratory, digestive, and nervous systems. The resulting dataset ...
A new type of artificial saliva, delivered as a mouthwash and made using a lab-modified sugarcane protein called CANECPI-5, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results